Products for Research Use Only
RegisterLogin

GLY-230

CAT: 0804-HY-106661Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-106661Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GLY-230 is an orally active compound. GLY-230 can inhibit nonenzymatic glycation and reduce glycated albumin. GLY-230 can reduce brain Aβ42 levels. GLY-230 can be used for the researches of metabolic and neurological disease, such as diabetic renal dysfunction[1][2].
CAS Number
320777-05-7
UNSPSC
12352005
Target
Amyloid-β
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Metabolic Disease; Neurological Disease
Smiles
OC(CC(C=CC=C1)=C1NC2=CC(Cl)=CC=C2)=O
Molecular Formula
C14H12ClNO2
Molecular Weight
261.70
References & Citations
[1]Kennedy L, et al. Anti-glycation and anti-albuminuric effects of GLY-230 in human diabetes. Am J Nephrol. 2010;31 (2) :110-6.|[2]Cohen MP, et al. Reduction of Abeta42 in brains of transgenic APPswe mice by 2-3-chlorophenylaminophenylacetate. Clin Exp Pharmacol Physiol. 2009 Nov;36 (11) :1099-103.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-117473DAT-230
HY-106279-01EA-230
HY-19060TMA-230
HY-165426HB-230
HY-44370-01Boc-Gly-Gly-Gly-Gly-Gly
HY-151777-01N3-Gly-Gly-Gly-Gly-Gly-OH
HY-172564BTR2000-Gly-Gly-Gly
HY-P3669-01Gly-Gly-Phe-Gly
HY-W1008866CRBN ligand-230
HY-161822Antibacterial agent 230

Alternative Products

CatalogName
T70527-01DAT-230
110077Hsp-230
GTR19030187-01EA-230
RG-E141376-01Gly-Gly-Gly-Gly
278577-01Gly-Gly-Gly-Gly-Gly-OH
OR1006194Boc-Gly-Gly-Gly-Gly-Gly
FG108994-01H-Gly-Gly-Gly-Gly-Gly-Gly-OH
C-1760.0250Z-Gly-Gly-Gly-Gly-Gly-Gly-OH
M40511Gly-Gly-Gly|H-Gly-Gly-Gly-OH
MBS406230-01Gly-Gly-Gly

Popular Products